No profile data available.
ICU Medical, Inc. (ICUI) is a healthcare company in the IV treatment equipment industry, based in San Clemente, United States, with about 13,000 full-time employees.
It reported revenue of $2.23 billion for fiscal year 2025, down 6.3% from fiscal year 2024, and net income of $732,000. United States was its largest region in fiscal year 2025, with 61% of revenue. Its market capitalization was $4.01 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
ICU Medical reported $2.23 billion in revenue for fiscal year 2025, down 6.3% from $2.38 billion in fiscal year 2024.
United States: 61% of revenue by region in fiscal year 2025, followed by Europe, The Middle East and Africa (18%).
$4.01 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (IV treatment equipment) include Insulet Corporation (PODD), Tandem Diabetes Care, Inc. (TNDM), Iradimed Corporation (IRMD), Beta Bionics, Inc. (BBNX).